Frontage Expands Clinical Operations in Secaucus, NJ
News May 07, 2015
Frontage has announced the opening of its newest facility in Secaucus, NJ to expand its clinical research portfolio of services.
As part of Frontage’s strategic growth plans to broaden clinical service capabilities and increase capacity, the company has completed construction of its new 36,000-square-foot 160-bed clinical research center in Secaucus, NJ.
The location of the new facility complements the existing center in nearby Hackensack. The Secaucus facility will include the ability to conduct a wider range of clinical studies including multiple concurrent studies and Phase II-IV studies involving patient populations. This expansion will nearly triple the company’s clinical capacity in the USA.
“We are excited to operate a second facility in New Jersey as it has been an ideal location for our clinical research due to the immediate access to the medical communities as well as subject and patient populations,” said Eileen McAuley, Senior Vice President of Clinical Services.
“Frontage’s ability to provide comprehensive support to our clients and their needs in the early drug development stage is greatly enhanced by our investment in facility expansion and clinical services infrastructure,” said Dr. Song Li, CEO of Frontage.
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Vapourtec Collaboration with NPM Drives New Flow TechnologyNews
Flow chemistry engineering specialists Vapourtec (UK) have been engaged in a successful collaboration with New Path Molecular Research Ltd (NPM), focusing on the development of new reactor technology and methods for peptide synthesis.READ MORE